Regeneron
Trade Regeneron 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About REGN
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara.
REGN Key Statistics
Stock Snapshot
Regeneron(REGN) stock is priced at $781.67, giving the company a market capitalization of 82.58B. It carries a P/E multiple of 18.58 and pays a dividend yield of 45.7%.
During the trading session on 2026-02-28, Regeneron(REGN) shares reached a daily high of $786.68 and a low of $760.91. At a current price of $781.67, the stock is +2.7% higher than the low and still -0.6% under the high.
Trading volume for Regeneron(REGN) stock has reached 723.1K, versus its average volume of 690.78K.
The stock's 52-week range extends from a low of $476.49 to a high of $821.11.
The stock's 52-week range extends from a low of $476.49 to a high of $821.11.
REGN News
Opko Health ((OPK)) has held its Q4 earnings call. Read on for the main highlights of the call. Claim 50% Off TipRanks Premium Unlock hedge fund-level data and...
Regeneron Pharmaceuticals (REGN) and Sanofi (SNY) announced that the European Medicines Agency’s, EMA, Committee for Medicinal Products for Human Use, CHMP, ado...
The latest catalyst for Regeneron Pharmaceuticals (REGN) is US FDA approval of Dupixent for allergic fungal rhinosinusitis in patients 6 and older with prior si...
Analyst ratings
72%
of 29 ratingsMore REGN News
(RTTNews) - Sanofi (SNY, SAN.PA) said FDA has approved Dupixent or dupilumab for the treatment of adult and pediatric patients aged 6 years and older with aller...
Regeneron Pharmaceuticals and Sanofi recently received U.S. FDA approval for Dupixent to treat allergic fungal rhinosinusitis (AFRS) in adults and children aged...
• Regeneron Pharmaceuticals stock is facing resistance. Why are REGN shares declining? AFRS is a condition characterized by allergic hypersensitivity to fungi,...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.